156 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Alder BioPharmaceuticals Funding History

Since Alder BioPharmaceuticals was founded in 2004, it has participated in 8 rounds of funding. In total Alder BioPharmaceuticals has raised $610.0M. Alder BioPharmaceuticals' last funding round was on Jan 2018 for a total of $100.0M.

Alder BioPharmaceuticals Funding Rounds

Unlock 5 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Equity
Jan 2018
$100M
__
Secondary Offering
Apr 2016
$125M
__
Secondary Offering
Jun 2015
$200M
__
IPO
May 2014
$80M
__
Series D
Apr 2012
$38M
6
Novo Ventures,  TPG Biotech,  Delphi Ventures,  Sevin Rosen Funds,  Ventures West,  WRF Capital

Total Funding: $610M

Alder BioPharmaceuticals Investors

Unlock 5 more investors →

INVESTOR

ROUND

FUNDING DATE

Novo Ventures
Series D
Apr 2012
TPG Biotech
Series D, Series C
Apr 2012, Jan 2008
Delphi Ventures
Series D, Series C
Apr 2012, Jan 2008
Sevin Rosen Funds
Series D, Series B, Series A
Apr 2012, Jun 2006, Jun 2005
Ventures West
Series D, Series B
Apr 2012, Jun 2006

Total Investors: 8

Alder BioPharmaceuticals has 8 investors, including Novo Ventures, TPG Biotech and Delphi Ventures. The latest investment occurred in Jan 2018.